Department of Pharmaceutical Technology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland.
Department of Clinical Pharmacy, Medical University of Bialystok, Mickiewicza 2a, 15-222 Bialystok, Poland.
Int J Mol Sci. 2019 Jun 29;20(13):3200. doi: 10.3390/ijms20133200.
In the pharmaceutical technology, paediatric population still presents the greatest challenge in terms of developing flexible and appropriate drug dosage forms. As for many medicines, there is a lack of paediatric dosage forms adequate for a child's age; it is a prevailing practice to use off label formulations. Children need balanced and personalized treatment, patient-friendly preparations, as well as therapy that facilitates dosing and thus eliminates frequent drug administration, which can be ensured by modified release (MR) forms. MR formulations are commonly used in adult therapy, while rarely available for children. The aim of this article is to elucidate how to modify drug release in paediatric oral dosage forms, discuss the already accessible technologies and to introduce novel approaches of manufacturing with regard to paediatric population.
在制药技术方面,儿科人群在开发灵活且适用的药物剂型方面仍然面临着最大的挑战。对于许多药物来说,缺乏适合儿童年龄的儿科剂型;因此,普遍采用超说明书制剂。儿童需要平衡和个性化的治疗、适合患者的制剂,以及便于给药从而避免频繁给药的治疗方法,这可以通过控释(MR)制剂来实现。MR 制剂在成人治疗中常用,但很少用于儿童。本文旨在阐明如何在儿科口服剂型中调节药物释放,讨论已有的技术,并介绍针对儿科人群的新型制造方法。